13 completed, 3 recruiting, 2 not yet recruiting. 9 Phase 3, 5 Not applicable, 3 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
| Not applicable | 5 | Completed 2, Recruiting 2, Not yet recruiting 1 |
| Phase 2 | 3 | Completed 2, Not yet recruiting 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow mirogabalin: new trials by email Literature Review of mirogabalin trials Research Report on mirogabalin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Mirogabalin in Uremic Pruritus Mirogabalin (Intermittent), Mirogabalin (Daily), Placebo - Uremic Pruritus | Phase 2 | Not yet recruiting | Alexandria University | 120 | 2026-12-01 | 2026-11-13 |
| Perioperative Mirogabalin for Pain Relief After Modified Radical Mastectomy Mirogabalin, Placebo - Breast Cancer, Post Operative Pain | Not applicable | Not yet recruiting | Cairo University | 50 | 2026-10-15 | 2026-10-19 |
| Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain Mirogabalin, Pregabalin - Diabetic Peripheral Neuropathic Pain (DPNP) | Phase 4 | Recruiting | Bangladesh Medical University | 78 | 2025-10-01 | 2026-03-09 |
| The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With Fibromyalgia Mirogabalin, Pregabalin - Fibromyalgia, Pregabalin | Not applicable | Recruiting | Beijing Tiantan Hospital | 674 | 2025-09-05 | 2026-06-25 |
| Comparison of the Efficacy and Safety of Mirogabalin and Duloxetine in Chemotherapy-induced Peripheral Neuropathy in a Randomized Controlled Trial: a Quality of Life Study in Cancer Survivors Mirogabalin, Duloxetine - CIPN, CIPN - Chemotherapy-Induced Peripheral Neuropathy | Not applicable | Completed | Pusan National University Yangsan Hospital | 66 | 2024-12-01 | 2026-08-26 |
| Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA Mirogabalin, Pregabalin - Pain Postoperative, Osteoarthritis | Not applicable | Recruiting | Thammasat University Hospital | 80 | 2024-04-01 | 2026-08-07 |
| A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled 14-week Study of DS-5565 in Chinese Patients With Diabetic Peripheral Neuropathic Pain Mirogabalin, Placebo - Diabetic Peripheral Neuropathic Pain | Phase 3 | Completed | Daiichi Sankyo Co., Ltd. | 393 | 2019-09-18 | 2022-10-24 |
| Study of Mirogabalin for Central Neuropathic Pain Placebo, Mirogabalin - Central Neuropathic Pain | Phase 3 | Completed | Daiichi Sankyo Co., Ltd. | 300 | 2019-03-12 | 2024-10-21 |
| DS-5565 Phase III Study for Renal Impairment in Japanese Subjects DS-5565 - Diabetic Peripheral Neuropathic Pain, Post-herpetic Neuralgia | Phase 3 | Completed | Daiichi Sankyo Co., Ltd. | 35 | 2015-12-01 | 2021-05-13 |
| Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease DS-5565, Placebo - Fibromyalgia | Phase 3 | Completed | Daiichi Sankyo | 56 | 2015-06-26 | 2020-11-24 |
| An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia DS-5565 - Pain Associated With Fibromyalgia | Phase 3 | Completed | Daiichi Sankyo | 2485 | 2015-02-04 | 2020-07-23 |
| Treatment of Pain Associated With Fibromyalgia DS-5565, Pregabalin, Placebo tablet - Pain Associated With Fibromyalgia | Phase 3 | Completed | Daiichi Sankyo | 1301 | 2015-01-16 | 2020-11-09 |
| DS-5565 Phase III Study for Post-herpetic Neuralgia Placebo, DS-5565 - Post-Herpetic Neuralgia | Not applicable | Completed | Daiichi Sankyo Co., Ltd. | 765 | 2015-01-01 | 2020-11-02 |
| DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain DS-5565, placebo - Diabetic Peripheral Neuropathic Pain | Phase 3 | Completed | Daiichi Sankyo Co., Ltd. | 854 | 2015-01-01 | 2020-11-02 |
| Treatment of Pain Associated With Fibromyalgia DS-5565, Pregabalin, Placebo tablet - Pain Associated With Fibromyalgia | Phase 3 | Completed | Daiichi Sankyo | 1270 | 2014-11-01 | 2020-11-09 |
| Treatment of Pain Associated With Fibromyalgia DS-5565, Pregabalin, Placebo tablet - Pain Associated With Fibromyalgia | Phase 3 | Completed | Daiichi Sankyo | 1293 | 2014-10-27 | 2020-11-09 |
| Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy DS-5565, Placebo, Pregabalin capsules - Pain, Diabetic Peripheral Neuropathy | Phase 2 | Completed | Daiichi Sankyo Co., Ltd. | 450 | 2012-01-01 | 2020-03-18 |
| Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy DS-5565 tablet, pregabalin capsule, Placebo tablet - Diabetic Peripheral Neuropathy | Phase 2 | Completed | Daiichi Sankyo | 452 | 2011-11-28 | 2021-01-05 |
Pain (7) · Fibromyalgia (6) · Neuralgia, Postherpetic (2) · Pain, Postoperative (2) · Breast Neoplasms (1) · Diabetes Mellitus (1) · Osteoarthritis (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1)
Daiichi Sankyo (6) · Daiichi Sankyo Co., Ltd. (6) · Alexandria University (1) · Bangladesh Medical University (1) · Beijing Tiantan Hospital (1) · Cairo University (1) · Pusan National University Yangsan Hospital (1) · Thammasat University Hospital (1)
United States (6) · Japan (5) · Bulgaria (3) · Czechia (3) · Hungary (3) · Poland (3) · Romania (3) · South Korea (3) · Spain (3) · Australia (2) · Austria (2) · Canada (2) · Chile (2) · China (2) · Denmark (2)
Domenico Merante, MD (1) · Mohamed A Abdelhalim, MD (1) · Mohamed Mamdouh Elsayed, MD (1) · Sayed Abed, MD (1)
PMID 31284771, PMID 34059327, PMID 25261162, PMID 28119855, PMID 31798378, PMID 32052264, PMID 32586656, PMID 32663120, PMID 32765056, PMID 32899037, PMID 33380563, PMID 34174668, PMID 36517235, PMID 37115464, PMID 37951905, PMID 38896199, PMID 38963656, PMID 42642082
2014 (1)